Nongfu Spring Co Ltd
F:7NF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nongfu Spring Co Ltd
F:7NF
|
CN |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
US |
|
I
|
IHI Corp
DUS:IWJ
|
JP |
|
J
|
Jasmine International PCL
SET:JAS
|
TH |
|
Z
|
Zions Bancorporation NA
XBER:ZB1
|
US |
Wall St Price Targets
7NF Price Targets Summary
Nongfu Spring Co Ltd
According to Wall Street analysts, the average 1-year price target for 7NF is 7.72 EUR with a low forecast of 5.183 EUR and a high forecast of 9.306 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7NF's stock price target?
Price Target
7.72
EUR
According to Wall Street analysts, the average 1-year price target for 7NF is 7.72 EUR with a low forecast of 5.183 EUR and a high forecast of 9.306 EUR.
What is the Revenue forecast for Nongfu Spring Co Ltd?
Projected CAGR
13%
Over the last 7 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Nongfu Spring Co Ltd?
Projected CAGR
13%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Nongfu Spring Co Ltd?
Projected CAGR
6%
Over the last 7 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Nongfu Spring Co Ltd?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 24%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Nongfu Spring Co Ltd?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 12%.
